𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interleukin 12: `encouraging' antiviral effect in hepatitis C

Book ID
120865025
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2001
Weight
167 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Antiviral effect of human recombinant in
Antiviral effect of human recombinant interleukin-12 in patients infected with hepatitis C virus
✍ Lee, Jung-Hun; Teuber, Gerlinde; von Wagner, Michael; Roth, Willi Kurt; Zeuzem, πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 293 KB πŸ‘ 2 views

The heterogeneity of hepatitis C virus (HCV) is due to the continuous and high replication rate, the low fidelity of the RNA-dependent RNA polymerase, and the immune surveillance of the host. Interleukin-12 (IL-12) plays a central role in mounting an effective cellular immune response directed towar

Production of interleukin-18 and interle
Production of interleukin-18 and interleukin-12 in patients suffering from chronic hepatitis C virus infection before antiviral therapy
✍ E. Schvoerer; M.C. Navas; C. Thumann; A. Fuchs; N. Meyer; F. Habersetzer; F. Sto πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 124 KB

## Abstract Interleukin‐12 and ‐18 (IL‐12 and IL‐18) are known to enhance the cytotoxic T‐lymphocyte response synergistically, but their precise involvement in hepatitis C virus (HCV) infection is not well known, especially for IL‐18. Enzyme‐linked immunosorbent assay (ELISA) was used to study the

Lamivudine plus interleukin-12 combinati
Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: Antiviral and immunological activity
✍ Eirini I. Rigopoulou; Deepak Suri; Shilpa Chokshi; Ivana Mullerova; Steven Rice; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 381 KB

Interleukin-12 (IL-12) is an immunomodulatory cytokine that promotes cellular immunity. Pre-clinical data suggest that IL-12 inhibits hepatitis B virus (HBV) replication by stimulating interferon-gamma (IFN-gamma) production. We investigated whether a combination treatment with lamivudine plus recom